• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶基因插入/缺失(I/D)多态性及其与2019冠状病毒病易感性和严重程度的关系:一项系统评价和荟萃分析。

Insertion/deletion (I/D) polymorphisms of angiotensin-converting enzyme gene and their implications for susceptibility and severity of COVID-19: A systematic review and meta-analysis.

作者信息

Fajar Jonny K, Tamara Fredo, Putranto Wachid, Prabowo Nurhasan A, Harapan Harapan

机构信息

Department of Internal Medicine, Rumah Sakit Universitas Brawijaya, Malang, Indonesia.

Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.

出版信息

Narra J. 2024 Dec;4(3):e727. doi: 10.52225/narra.v4i3.727. Epub 2024 Dec 21.

DOI:10.52225/narra.v4i3.727
PMID:39816082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731805/
Abstract

The insertion or deletion polymorphisms of the () have been the subject of significant research related to coronavirus disease 2019 (COVID-19). Despite this, the findings have remained uncertain and debatable. The aim of this study was to determine the associations between the polymorphisms and the susceptibility as well as the severity of COVID-19. A meta-analysis study (PROSPERO: CRD42022384562) was conducted by searching the articles published on PubMed, Scopus, and Embase as of May 15, 2023. Information regarding the impact of variant on the susceptibility to COVID-19 and its severity was collected and analyzed utilizing the Mantel-Haenszel method with a random effects model or fixed effects model, depending on the presence or absence of heterogeneity. Out of 3,335 articles, 21 articles were included, of which 13 investigated the association between and the risk of COVID-19 infection and 18 of them examined its influence on disease severity. The D allele of increased risk of COVID-19 infection (OR: 1.41; 95%CI: 1.08-1.85; -Egger: 0.0676; -Heterogeneity: <0.001; =0.0120), while I allele (OR: 0.71; 95%CI: 0.54-0.93; -Egger: 0.0676; -Heterogeneity: <0.001; =0.012) and II genotype (OR: 0.55; 95%CI: 0.34-0.87; -Egger: 0.200; -Heterogeneity: <0.001; =0.011) decreased the risk of infection. Additionally, there was a notable association between the genotype and an elevated likelihood of experiencing severe COVID-19 within the Asian population (OR: 1.46; 95%CI: 1.15-1.84; -Egger: 0.092; -Heterogeneity: 0.116; =0.002). The presence of polymorphisms significantly influences the likelihood of being susceptible to and experiencing the severity of COVID-19.

摘要

()的插入或缺失多态性一直是与2019冠状病毒病(COVID-19)相关的重要研究课题。尽管如此,研究结果仍不确定且存在争议。本研究的目的是确定()多态性与COVID-19易感性以及严重程度之间的关联。通过检索截至2023年5月15日在PubMed、Scopus和Embase上发表的文章进行了一项荟萃分析研究(PROSPERO:CRD42022384562)。根据异质性的有无,采用随机效应模型或固定效应模型的Mantel-Haenszel方法收集并分析了有关()变体对COVID-19易感性及其严重程度影响的信息。在3335篇文章中,纳入了21篇文章,其中13篇研究了()与COVID-19感染风险之间的关联,其中18篇研究了其对疾病严重程度的影响。()的D等位基因增加了COVID-19感染风险(OR:1.41;95%CI:1.08-1.85;-Egger:0.0676;-异质性:<0.001;=0.0120),而()的I等位基因(OR:0.71;95%CI:0.54-0.93;-Egger:0.0676;-异质性:<0.001;=0.012)和II基因型(OR:0.55;95%CI:0.34-0.87;-Egger:0.200;-异质性:<0.001;=0.011)降低了感染风险。此外,在亚洲人群中,()基因型与经历严重COVID-19的可能性增加之间存在显著关联(OR:1.46;95%CI:1.15-1.84;-Egger:0.092;-异质性:0.116;=0.002)。()多态性的存在显著影响易患COVID-19及其严重程度的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/c637db24b9e5/NarraJ-4-e727-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/44e207f8d54f/NarraJ-4-e727-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/538e45b219c6/NarraJ-4-e727-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/42c82b53636c/NarraJ-4-e727-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/c637db24b9e5/NarraJ-4-e727-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/44e207f8d54f/NarraJ-4-e727-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/538e45b219c6/NarraJ-4-e727-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/42c82b53636c/NarraJ-4-e727-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24a2/11731805/c637db24b9e5/NarraJ-4-e727-g004.jpg

相似文献

1
Insertion/deletion (I/D) polymorphisms of angiotensin-converting enzyme gene and their implications for susceptibility and severity of COVID-19: A systematic review and meta-analysis.血管紧张素转换酶基因插入/缺失(I/D)多态性及其与2019冠状病毒病易感性和严重程度的关系:一项系统评价和荟萃分析。
Narra J. 2024 Dec;4(3):e727. doi: 10.52225/narra.v4i3.727. Epub 2024 Dec 21.
2
ACE and ACE2 activities and polymorphisms assessment: A populational study from Ipaussu (SP, Brazil) during the COVID-19 pandemic.ACE 和 ACE2 活性及多态性评估:COVID-19 大流行期间巴西伊普阿苏(SP)的一项人群研究。
Life Sci. 2024 Dec 1;358:123157. doi: 10.1016/j.lfs.2024.123157. Epub 2024 Oct 20.
3
Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.ACE(I/D)和 ACE2 受体基因(Rs2106809、Rs2285666)多态性与 COVID-19 的临床病程无关:一项病例研究。
J Med Virol. 2021 Oct;93(10):5947-5952. doi: 10.1002/jmv.27160. Epub 2021 Jul 10.
4
Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.血管紧张素转换酶插入/缺失多态性、ACE 活性与 COVID-19:一个颇具争议的假说。一项病例对照研究。
J Med Virol. 2022 Mar;94(3):1050-1059. doi: 10.1002/jmv.27417. Epub 2021 Nov 5.
5
Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis.血管紧张素转换酶基因插入/缺失多态性与经皮冠状动脉介入治疗后冠状动脉再狭窄风险的相关性:一项荟萃分析。
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):844-50. doi: 10.1177/1470320315588233. Epub 2015 Jul 20.
6
Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis.血管紧张素转化酶插入/缺失多态性与 COVID-19 风险的关系:荟萃分析。
J Renin Angiotensin Aldosterone Syst. 2023 Nov 28;2023:3431612. doi: 10.1155/2023/3431612. eCollection 2023.
7
Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) gene polymorphism with susceptibility to prostate cancer: an updated meta-analysis.血管紧张素转化酶插入/缺失(ACE I/D)基因多态性与前列腺癌易感性的关联:一项更新的荟萃分析。
World J Surg Oncol. 2022 Nov 4;20(1):354. doi: 10.1186/s12957-022-02812-x.
8
Angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to psoriasis: a systematic review and meta-analysis.血管紧张素转化酶基因插入/缺失多态性与银屑病易感性:系统评价和荟萃分析。
BMC Med Genet. 2020 Jan 8;21(1):8. doi: 10.1186/s12881-019-0943-3.
9
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.血管紧张素转换酶2基因插入/缺失多态性与对严重急性呼吸综合征冠状病毒2的易感性、高血压、冠状动脉疾病及2019冠状病毒病死亡率的强关联
J Pers Med. 2021 Oct 27;11(11):1098. doi: 10.3390/jpm11111098.
10
Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies.血管紧张素转换酶插入/缺失多态性增加亚洲男性高血压患者慢性肾脏病风险——98 项观察性研究的荟萃回归分析。
PLoS One. 2014 Jan 31;9(1):e87604. doi: 10.1371/journal.pone.0087604. eCollection 2014.

本文引用的文献

1
The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry.世卫组织 COVID-19 严重程度分类、COVID-GRAM、VACO 指数、4C 死亡率和 CURB-65 预后评分在住院 COVID-19 患者中的表现:来自三级中心登记处的 4014 例患者的数据。
Croat Med J. 2023 Feb 28;64(1):13-20. doi: 10.3325/cmj.2023.64.13.
2
Polymorphisms in , , , , and Genes Are Associated with Worse Clinical Outcomes in COVID-19.基因、、、和中的多态性与 COVID-19 的临床结局恶化相关。
Genes (Basel). 2022 Dec 22;14(1):29. doi: 10.3390/genes14010029.
3
The Relation between ACE Gene Polymorphism and the Severity of COVID-19 Infection.
血管紧张素转换酶基因多态性与新型冠状病毒肺炎感染严重程度的关系
Int J Microbiol. 2023 Jan 4;2023:4540287. doi: 10.1155/2023/4540287. eCollection 2023.
4
The Association of Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity.基因型和可溶性 suPAR 血清水平与 COVID-19 相关肺损伤严重程度的关联。
Int J Mol Sci. 2022 Dec 19;23(24):16210. doi: 10.3390/ijms232416210.
5
The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients.血管紧张素I转换酶插入/缺失多态性在COVID-19患者严重程度及预后中的作用
Front Genet. 2022 Nov 29;13:1035796. doi: 10.3389/fgene.2022.1035796. eCollection 2022.
6
Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels.研究 ACE1 I/D 和 ACE2 rs2285666 多态性在肺受累程度不同的 COVID-19 患者中的频率和遗传模式及其对血清细胞因子水平的影响。
Cell Biol Int. 2023 Apr;47(4):731-741. doi: 10.1002/cbin.11977. Epub 2022 Dec 13.
7
Investigation of Serum Angiotensin-Converting Enzyme (ACE) Concentration and ACE Gene Polymorphism in Patients With SARS-CoV-2 Pneumonia Admitted to the Emergency Department.急诊科收治的新型冠状病毒肺炎患者血清血管紧张素转换酶(ACE)浓度及ACE基因多态性的研究
Cureus. 2022 Nov 7;14(11):e31201. doi: 10.7759/cureus.31201. eCollection 2022 Nov.
8
Analysis of Gene Single Nucleotide Polymorphisms in COVID-19 Disease Highlighting the Susceptibility and the Severity towards the Infection.新冠病毒病基因单核苷酸多态性分析突显对感染的易感性和严重性
Diagnostics (Basel). 2022 Nov 16;12(11):2824. doi: 10.3390/diagnostics12112824.
9
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism.靶向基因分析揭示 ACE I/D 和 APO T158C 多态性与伴有肺栓塞的重症 COVID-19 患者 D-二聚体水平之间的新关联。
J Thromb Thrombolysis. 2023 Jan;55(1):51-59. doi: 10.1007/s11239-022-02728-z. Epub 2022 Nov 13.
10
Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.ACE1 和 ACE2 多态性与 COVID-19 疾病严重程度的关联研究。
Mol Genet Genomics. 2023 Jan;298(1):27-36. doi: 10.1007/s00438-022-01953-8. Epub 2022 Oct 18.